| Jul 15 |
GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research
|
| Jul 12 |
Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying
|
| Jul 11 |
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
|
| Jul 11 |
Insiders Buying Fortress Biotech And 2 Other Stocks
|
| Jul 8 |
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
|
| Jul 5 |
Fortress Biotech pauses dividend payments on preferred stock
|
| Jul 5 |
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
| Jul 2 |
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Jul 2 |
Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
|
| Jun 24 |
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
|
